Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	1.5 mg Dulaglutide	244
Overall Study	STARTED	0.75 mg Dulaglutide	248
Overall Study	STARTED	Glimepiride	245
Overall Study	Received at Least One Dose of Study Drug	1.5 mg Dulaglutide	244
Overall Study	Received at Least One Dose of Study Drug	0.75 mg Dulaglutide	248
Overall Study	Received at Least One Dose of Study Drug	Glimepiride	243
Overall Study	Modified Intent-to-treat Population	1.5 mg Dulaglutide	239
Overall Study	Modified Intent-to-treat Population	0.75 mg Dulaglutide	239
Overall Study	Modified Intent-to-treat Population	Glimepiride	242
Overall Study	COMPLETED	1.5 mg Dulaglutide	222
Overall Study	COMPLETED	0.75 mg Dulaglutide	224
Overall Study	COMPLETED	Glimepiride	230
Overall Study	NOT COMPLETED	1.5 mg Dulaglutide	22
Overall Study	NOT COMPLETED	0.75 mg Dulaglutide	24
Overall Study	NOT COMPLETED	Glimepiride	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01644500/flow